logo

Breaking News

Share

Seattle Genetics, Inc. (SGEN) and Astellas Pharma Inc. (ALPMY, ALPMY) have submitted a Biologics License Application to the U.S. FDA for the accelerated approval of Enfortumab Vedotin for patients with locally advanced or metastatic urothelial cancer. Enfortumab vedotin, an investigational antibody-drug...

Wells Fargo & Company (WFC) said its second-quarter net income was up 26% year-on-year driven by net discrete tax expense of $481 million in the second quarter of previous year. The company grew period-end loans and deposits, as well as pre-tax pre-provision profit from prior year. Revenue was flat compared...

JPMorgan Chase & Co. (JPM) reported a profit for the second quarter that increased 16 percent from last year, driven by its diversified global business model and an income tax benefit related to the resolution of certain tax audits. Both earnings per share and revenue for the quarter beat analysts' expectations. Net...

KeyCorp (KEY) said it has found out a fraudulent activity by a business customer which could result in a potential loss to company of up to $90 million, net of tax. The transactions were conducted in the third quarter of 2019 by a business customer of KeyBank National Association. KeyCorp said it is...

While reporting financial results for the second quarter, Johnson & Johnson (JNJ) on Tuesday maintained its adjusted earnings forecast for the full year 2019, while raising sales outlook. For fiscal 2019, the company maintained its outlook for adjusted earnings in the range of $8.53 to $8.63 per share....

Commerce Bancshares, Inc. (CBSH) reported earnings of $0.96 per share for the second quarter, flat with last year. On average, 9 analysts polled by Thomson Reuters expected the company to report earnings of $0.93 per share for the quarter. Analysts' estimates typically exclude special items. Total...

Shares of Bayer Group (BAYZF.PK, BAYRY.PK, BYR.L) were gaining around 2 percent in German trading after a U.S. judge Monday reduced jury award related to weedkiller Roundup to $25.3 million from $80.3 million. In the case by a California man who blamed Roundup for his cancer, U.S. District Judge Vince...

Shares of Groupe Renault (RNSDY.PK, RNSDF.PK, RNT.L) were losing around 1 percent in Paris trading after the French carmaker reported weak volume in its first half. The company, however, maintained its market share of 4.4 percent in the first half of the year in a sharply declining market. In...

Australian Competition & Consumer Commission or ACCC announced Tuesday that Vodafone Group Plc (VOD.L, VOD), following an investigation, has admitted to making false or misleading representations about its third-party Direct Carrier Billing or DCB service. The company will now contact and refund impacted...

Irish low-cost airline Ryanair Holdings (RYA.L) Tuesday said it expects Boeing 737 MAX delivery delays to slow capacity growth for winter 2019 and summer 2020. In its update to investors on the current uncertainty over the 737 MAX deliveries, Ryanair CEO Michael O'Leary said the exact date of the...

Burberry Group plc (BRBY.L) reported Tuesday that its first-quarter comparable sales increased 4 percent, compared to a 3 percent growth last year. Quarterly retail revenue grew 4 percent to 498 million pounds from the prior year. At constant exchange rates, retail revenues increased 2 percent. The...

A.G. BARR plc (BAG.L), a producer of drinks brands, Tuesday said it expects first-half revenue to be in the region of 123 million pounds, around 10% lower than last year's 136 million pounds. The company said its trading in the financial year to date has been below expectations. Looking ahead,...

Experian plc. (EXPN.L), an information services company, reported Tuesday that its first-quarter total revenue increased 4 percent on a reported basis and 7 percent at constant exchange rates. On an organic basis, revenue grew 6 percent. In its trading update, the company said its North American...

Nomura Securities International Inc., a unit of Japanese financial holding company Nomura Holdings, Inc., agreed to repay customers about $25 million to settle charges in U.S. for its failure to adequately supervise traders in mortgage-backed securities. The U.S. Securities and Exchange Commission...

Novartis (NVS) said Tuesday that the US Food and Drug Administration accepted the company's Biologics License Application or BLA and granted Priority Review for its investigational sickle cell medicine crizanlizumab or SEG101. If FDA-approved, crizanlizumab is expected to represent the first monoclonal...

Follow RTT